Clinical trial

Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder

University of Wisconsin, MadisonTerminatedPhase 1Started Mar 3, 20235 enrolledUnited StatesNCT05322954

Abstract

The purpose of this research study is to investigate the safety and feasibility of two (2) oral doses of psilocybin when combined with behavioral support for methamphetamine use disorder (MUD). Participants have a diagnosis of methamphetamine use disorder (MUD). Participants can expect to be actively engaged in the study for up to 26 weeks.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinAddiction

Keywords

methamphetaminepsychedelicsstimulantssubstance useMethamphetamine Use DisorderSubstance-Related DisordersChemically-Induced DisordersSubstance Use DisordersStimulant-Use Disorder

View on registry

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

PreprintPsilocybin

Confirmatory factor analysis of Mystical Experience in Freediving as a recreative way to higher efficiency in sport performance and planet saving and money making

Mitina O, Mirsaidov M, Molchanova N +1

Europe PMC2020

ArticlePsilocybin

Pharmacotherapy to Prevent Alcohol Relapse in Alcohol-Associated Liver Disease.

Zhang W, Hwang SY, Luther J

Europe PMC2025

ArticlePsilocybin

Psychedelic substitution: altered substance use patterns following psychedelic use in a global survey.

Glynos NG, Aday JS, Kruger D +3

Europe PMC2024